Rich nations, Covid-19 vaccine makers should stop bilateral deals: WHO

WHO chief appealed on Friday to makers of Covid-19 vaccines and the wealthier countries buying them to stop making bilateral deals, saying they hurt a UN-backed effort to widen access to the jabs.

Coronavirus, vaccine, vaccination, immunisation, covid, hospital, medical, infra, health, patient
The second nationwide vaccination mock drill was held on Friday at three session sites across 33 states and union territories | Photo: PTI
AP Geneva
3 min read Last Updated : Jan 09 2021 | 7:49 AM IST

The World Health Organisation chief appealed on Friday to makers of COVID-19 vaccines and the wealthier countries buying them to stop making bilateral deals, saying they hurt a UN-backed effort to widen access to the jabs.

Tedros Adhanom Ghebreyesus said 42 countries are now rolling out such vaccines, mostly high-income and a few middle-income countries. He called on countries that have more jabs than they need to make some available to the COVAX Facility the UN-backed project to get vaccines deployed widely.

Now, we are also seeing both high- and middle-income countries that are part of COVAX making additional bilateral deals, he told reporters in Geneva. This potentially bumps up the price for everyone and means high-risk people in the poorest and most marginalized countries don't get the vaccine. I urge countries and manufacturers to stop making bilateral deals at the expense of COVAX, said Tedros, the WHO director-general.

Tedros also urged manufacturers to make the data about their vaccines available, which is needed for the U.N. health agency to be able to provide emergency use listings that can expedite their deployment.

The lack of such data blocks the whole system of procurement and delivery, he said.

WHO officials, who generally shun finger-pointing at specific countries and companies that they need to work with, did not specify which ones need to do more to help broaden access to vaccines.

But Canada, for example, is known to have far greater access to vaccines that its population needs. And partners Pfizer and BioNTech, which make the first vaccine that received emergency use approval from the WHO and countries like the U.S. and Britain, have not reached a deal to take part in the COVAX Facility. Dr. Bruce Aylward, a special adviser to the WHO chief, said 50% of high-income countries are deploying vaccines and zero percent of poor countries are.

That is not equitable access, he said. The appeals come as the world has faced high case counts in recent weeks -- roughly 4 million new confirmed infections per week, said WHO emergencies chief Dr. Michael Ryan.

Tedros said some of the highest numbers of deaths recorded at any point in the pandemic have turned up in recent days, and faulted a lack of compliance with recommendations of health authorities. The WHO also said a team of experts who had originally expected to arrive in China this week to look into the origins of the pandemic had not yet arrived, saying that now, we expect to fix the travel dates next week. On Tuesday, Tedros said he was very disappointed that Chinese officials had not finalised the needed permissions for the team's arrival in China.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineWorld Health Organization

First Published: Jan 09 2021 | 7:47 AM IST

Next Story